Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Identification and functional characterization of brainstem cannabinoid CB2 receptors.

Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA.

Science. 2005 Oct 14;310(5746):329-32.

2.

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.

Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S.

J Mol Cell Cardiol. 2010 Jun;48(6):1187-93. doi: 10.1016/j.yjmcc.2009.10.025. Epub 2009 Nov 26.

PMID:
19931541
3.

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):87-92.

PMID:
15548432
4.

Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.

Mulè F, Amato A, Baldassano S, Serio R.

Pharmacol Res. 2007 Sep;56(3):185-92. Epub 2007 Jun 21.

PMID:
17656103
5.

The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis.

Grimaldi P, Orlando P, Di Siena S, Lolicato F, Petrosino S, Bisogno T, Geremia R, De Petrocellis L, Di Marzo V.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11131-6. doi: 10.1073/pnas.0812789106. Epub 2009 Jun 18.

6.

Functional CB2 type cannabinoid receptors at CNS synapses.

Morgan NH, Stanford IM, Woodhall GL.

Neuropharmacology. 2009 Sep;57(4):356-68. doi: 10.1016/j.neuropharm.2009.07.017. Epub 2009 Jul 16.

PMID:
19616018
7.

Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.

Pascual AC, Gaveglio VL, Giusto NM, Pasquaré SJ.

Exp Gerontol. 2014 Jul;55:134-42. doi: 10.1016/j.exger.2014.04.008. Epub 2014 Apr 24.

PMID:
24768821
8.

Expression and function of endocannabinoid receptors in the human adrenal cortex.

Ziegler CG, Mohn C, Lamounier-Zepter V, Rettori V, Bornstein SR, Krug AW, Ehrhart-Bornstein M.

Horm Metab Res. 2010 Feb;42(2):88-92. doi: 10.1055/s-0029-1241860. Epub 2009 Oct 27.

PMID:
19862666
9.

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.

Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A.

Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3376-80.

10.

Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.

Mulè F, Amato A, Baldassano S, Serio R.

Pharmacol Res. 2007 Aug;56(2):132-9. Epub 2007 May 10.

PMID:
17574859
11.

The endocannabinoid system is modulated in response to spinal cord injury in rats.

Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, Watanabe M, Guaza C, Di Marzo V, Molina-Holgado E.

Neurobiol Dis. 2009 Jan;33(1):57-71. doi: 10.1016/j.nbd.2008.09.015. Epub 2008 Sep 30.

PMID:
18930143
12.

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.

Shouman B, Fontaine RH, Baud O, Schwendimann L, Keller M, Spedding M, Lelièvre V, Gressens P.

Br J Pharmacol. 2006 Jun;148(4):442-51. Epub 2006 May 8.

13.

Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.

Habayeb OM, Taylor AH, Bell SC, Taylor DJ, Konje JC.

Endocrinology. 2008 Oct;149(10):5052-60. doi: 10.1210/en.2007-1799. Epub 2008 Jul 3.

PMID:
18599552
14.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678
15.

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

Spoto B, Fezza F, Parlongo G, Battista N, Sgro' E, Gasperi V, Zoccali C, Maccarrone M.

Biochimie. 2006 Dec;88(12):1889-97. Epub 2006 Aug 22.

PMID:
16949718
16.

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC.

J Pharmacol Exp Ther. 2002 Jun;301(3):1020-4.

17.

Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.

Schmidt W, Schäfer F, Striggow V, Fröhlich K, Striggow F.

Neuroscience. 2012 Dec 27;227:313-26. doi: 10.1016/j.neuroscience.2012.09.080. Epub 2012 Oct 13.

PMID:
23069763
18.

Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.

Wang PF, Jiang LS, Bu J, Huang XJ, Song W, Du YP, He B.

J Cardiovasc Pharmacol. 2012 Apr;59(4):301-7. doi: 10.1097/FJC.0b013e3182418997.

PMID:
22113346
19.
20.

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.

Pertwee RG.

Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Review.

PMID:
18482430

Supplemental Content

Support Center